Are you the publisher? Claim or contact us about this channel

Embed this content in your HTML


Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog

Channel Description:

Asia Business News

older | 1 | .... | 279 | 280 | (Page 281) | 282 | 283 | .... | 321 | newer

    0 0

    Anti-counterfeit and customer engagement solutions provider YPB Group Ltd (ASX:YPB) has secured strong support from a consortium of crypto pioneers who will take the YPB Token (YPT) directly to leading crypto exchanges and invest $1.5m in a YPB Convertible Note (to be issued subject to shareholder approval).

    - Blockchain and token pioneers to invest $1.5m and are engaged to exchange list the YPB Token

    - Heavily oversubscribed new equity issue raises additional $1.62m

    - Endorsement by leading blockchain companies for YPB's world leading anti-counterfeit technology and Token strategy

    - Greatly enhanced prospect of realising YPB US$30m token proceeds target

    The strategic investors are First Growth Funds (ASX:FGF), DigitalX (ASX:DCC) and Blockchain Global all of whom have deep expertise in blockchain, crypto currencies and crypto exchanges. With the support of these investors, it is intended that the YPT will be exchange listed and funds raised via the on-market sale of YPB Token (YPTs). Listing on quality exchanges is vitally important to the success of a Token and this direct access greatly enhances the prospect of achieving YPB's target of raising up to US$30m as previously advised to the market.

    The consortium will be invited to appoint a representative to the YPB Board. The equity investment, the directorship and potential direct benefits from the sale of YPTs strongly align the interests of YPB with those of the strategic investors. The investors are strongly incentivised to maximise the success of, and proceeds from, the YPB Token Issue and have the experience skills, experience, networks and access to do so.

    The objective of YPB's Token Issue is to fully fund the development and commercialisation of its smartphone readable Motif Micro technology and to blockchain-enable the YPB Connect serialisation and customer engagement platform. Together these solutions will allow certainty of authenticity to be offered in mass consumer markets globally.

    YPB has also raised $1.62m in new equity at $0.018 per share with one free attaching 18 month option with an exercise price of $0.025. Ninety million new shares will be issued presently and 90m new options will be issued subject to Shareholder approval at an upcoming EGM. The issue was 3.2x oversubscribed despite a tightly restricted offer audience.

    The goal of the total raise of $3.12m is to comfortably fund the company until the point of funding self-sufficiency through the combination of funds realised from token sales and/or business profitability. Should that goal be achieved, it is the Board's ambition to issue no further equity - absenting any major or unusual opportunity.

    The Convertible Note terms are:

    - A total investment of $1.5m.

    - 3 year fixed term, repayable only at maturity, non-redeemable.

    - Conversion at any time to ordinary equity at the lower of A$0.018 or a 50% discount to the price at which YPB shares were subscribed for pursuant to the most recent capital raising of YPB preceding the date of conversion (not including the present equity placement), provided that the deemed price is no lower than $0.009.

    - Free attaching unlisted option with an exercise price of $0.025. Option expiry 18 months from the date of conversion of the Note to shares.

    - Coupon 20% initially for the first $500K which reverts to 10% p.a. following shareholder approval for the entire Note investment.

    DigitalX CEO Leigh Travers commented; "We are pleased to advise publicly listed YPB on its upcoming token sale issue and are excited to see Blockchain technology applied to solving a real world problem of ensuring that fake goods do not infiltrate the supply chain for Australian businesses."

    "FGF is the cornerstone investor with a half-million-dollar investment, and we are pleased to have secured support from strategic groups such as DigitalX and Blockchain Global," said FGF Executive Director Anoosh Manzoori.

    Blockchain Global CEO Sam Lee commented; "Our association with YPB is an exciting fit with our recent $14m investment in a Japanese listed Company "Path Corp" (3840:TYO) which further strengthens our Global network incorporating strategic partnerships with FGF and DigitalX. The Utility of YPB's technology creates strong opportunity in the Asian Markets and we look forward to seeing Blockchain technology enhance its penetration."

    YPB's Executive Chairman John Houston said: "We did not plan to be raising further equity but our Token Issue fell well behind schedule for reasons beyond our control. Fortunately, that has proved a blessing in disguise as the impeccable credentials and capacity of our new strategic partners means the probability of a successful Token Issue is now extremely high. A successful Token Issue will be a boon for YPB, possibly creating material shareholder wealth and robust financial strength. It will increase the depth, appeal and market penetration of our products. I'm also excited by the opportunities beyond the token and blockchain that will open to YPB via our new strategic partners. I'm grateful to the support of all participants in our raise and welcome them to our register."

    YPB Token video link:

    Mr. John Houston 
    Executive Chairman
    YPB Group Limited
    Mr. Gerard Eakin
    YPB Group Limited

    0 0

    Your Directors present their report of Goldfields Money Limited (ASX:GMY) ("Goldfields Money" or the "Company") together with the financial report for the year ended 30 June 2018 and the auditor's report thereon.



    The principal activities of the Company were the provision of a range of retail banking products and services to existing and new customers. Goldfields Money Limited is a banking institution regulated by the Australian Prudential Regulation Authority ("APRA"). The Company has two branches in regional Western Australia, and has sought to diversify its credit and funding risk through leveraging third party distribution networks.


    The Company has recorded a statutory loss after income tax for the year ended 30 June 2018 of $406,699, an improvement of 59.2% on the prior year loss of $996,456. Underlying profit after tax, after accounting for the effects of costs of $938,862 incurred in responding to the Firstmac proposal and the Finsure transaction, was a $1,161,846 improvement on the prior year underlying loss of $629,680, which was net of the costs associated with the early termination of the previous core banking system.

    Building the business for growth

    FY18 saw significant efforts focused on setting the Company for future growth capabilities with the development and implementation of a new finance system and core banking system (CBS). The Temenos T24 Software as a Service (SaaS) system was successfully launched in April 2018 and will enhance the Company's ability to originate loans and deposits directly and through third party intermediaries into the future. This was a major milestone for a small team and underpins the Company's strategy going forward. Ongoing development of the system and process will continue into FY19 to ensure the full benefits of the T24 system are realised.

    The launch of the CBS is the result of significant investment that the Company has made in its people, products and processes over the last two years.

    In conjunction with the new CBS, the Company launched its newly branded website and mobile device app enhancing the accessibility and user experience for our customers.

    In October 2017, the Company received an unsolicited take-over from an entity associated with its then largest shareholder Firstmac Limited (Firstmac) which subsequently lapsed on 1 December 2017. On 23 November 2017, the Company and Finsure Holdings Pty Ltd (Finsure) announced the signing of a Process Agreement, which outlined the key commercial terms of a proposal under which the Company will merge with Finsure by acquiring 100% of the diluted shares in Finsure via the issue of Goldfields Money shares.

    On 15 January 2018, the Company announced it had satisfactorily completed the due diligence and agreed terms with Finsure to implement the merger, subject to appropriate approvals being obtained. The necessary regulatory approvals have now been obtained, and shareholders will have the opportunity to vote for the transaction at a meeting of shareholders to be held on 7 September 2018. The transaction, conditional upon the Company raising at least a further $15.3 million of capital, will result in the Company owning a fast growing national mortgage aggregation and wholesale mortgage business, significantly increasing the Company's scale, access to distribution capabilities and growth prospects.

    To view the full report, please visit:

    To view the investor presentation, please visit:

    Malcolm Cowell
    Company Secretary
    Phone: +61-8-9438-8811

    0 0

    WA-focused gold exploration and development company Classic Minerals Limited (ASX:CLZ) ("Classic", or "the Company") is pleased to announce that it has completed its latest drilling campaign at its Kat Gap project which is part of the Forrestania Gold Project (FGP) in Western Australia.


    - Kat Gap drill campaign successfully completed

    - Drilling campaign at Kat Gap was expanded by 50% from 12 holes to 18 holes

    - Multiple mineralised zones intersected with visible gold in panning dish

    - Strong mineralisation observed in deeper down dip extension holes

    - Step out RC holes to further test the newly-discovered granite-hosted gold mineralisation

    - Rig now onsite at Lady Lila and then Lady Magdalene

    - First assay results expected in 3 weeks


    In this round of drilling at Kat Gap, the Company increased its planned drill holes from 12 to 18 based upon multiple instances of promising mineralised zones and visible gold in a number of drill samples.

    Previous drilling results from Kat Gap confirms the discovery of a significant new zone of gold mineralisation within the granite which was previously thought to be barren. Drilling at Kat Gap also showed that high-grade gold mineralisation has effectively dammed up against a cross-cutting Proterozoic dyke (see ASX announcement dated 24 July 2018).

    Drilling is now underway at Lady Lila (5 holes testing mineralisation down dip and along strike) and Lady Magdalene (12 holes tracking high-grade quartz hosted gold confirmed in the last drill campaign).

    Classic CEO Dean Goodwin said:

    The Forrestania Gold Project continues to deliver fantastic results for Classic and its shareholders. We encountered high grade zones of mineralisation at each of the drill targets which all remain open along strike with high priority zones requiring urgent follow up. Kat Gap is shaping up to become a prolific shallow high-grade gold deposit with so much remaining upside potential. We have only tested >200m of 3.5km of potential strike along this granite-greenstone contact and received excellent gold grades from 11 of the 12 holes previously drilled.

    During this programme, after recognising encouraging mineralisation in the drill samples, I decided to increase the number of drill holes from 12 to 18 with the goal of extending the mineralised zone at the granite/greenstone contact.

    We also decided that further drill testing into the granite, which in our previous campaign, yielded surprising high-grade gold intervals, to gain further understanding of the mineralisation in this zone. Hole FKGRC034 was located 150m "in" the granite, away from the main mineralised contact zone.

    These new results bode well for the whole Forrestania project given that the main granite-greenstone contact, of which we have 40 km of strike, has been largely overlooked. I'm quite confident that new, high-priority gold targets will come to light elsewhere within the project area.


    Classic drilled 18 holes for ~1,600m at Kat Gap and is pleased to confirm that holes returned promising mineralisation striking in a north-south direction. The drilling was extending the 140m strike zone and testing the extent of the granite mineralisation.

    The majority of the drilling was focused on testing the main granite-greenstone contact which has been the sole focus of drilling since the prospect was discovered by previous holders. A few holes were also drilled up against the cross-cutting Proterozoic dyke where high-grade gold mineralisation is believed to have concentrated. This targeting was largely based on the success of the previous drill campaign where CLZ saw highlights such as the following: 8m @ 19.05 g/t Au from 32m including 4m @ 28.80 g/t Au from 32m in FKGRC008; 12m @ 7.52 g/t Au from 39m including 2m @ 20.20 g/t Au from 48m in FKGRC006; 12m @ 5.39 g/t Au from 30m including 1m @ 20.80 g/t Au from 30m in FKGRC012 and 4m @ 9.53 g/t Au from 70m including 1m @ 26.60 g/t Au from 72m in FKGRC014.

    It should be noted that a number of holes in the current campaign were drilled relatively close to the Proterozoic dyke to confirm and extend CEO Dean Goodwin's theory that gold is concentrated up against the dyke. With the promising mineralisation returned from these holes, Classic will continue to track mineralisation against the dyke and follow it down plunge. It is currently believed that two high grade gold shoots exist either side of the Proterozoic dyke contact. The strike and down-plunge extent of these shoots is currently but will be better understood after assays are returned.

    In addition, further step out drilling into the granite has been undertaken as part of this campaign to help determine the extent, style, grade of mineralisation hosted in the granite. One hole stepped out 150m from the contact zone into the granite. Assay results are pending.

    The decision to continue to investigate the granite mineralisation was based upon the previous drilling results (as reported in ASX announcement dated 24 July 2018) Holes FKGRC010 - FKGRC012 (inclusive) all drilled into a newly discovered footwall lode located approximately 30m west of the main granite-greenstone contact lode hosted within the granite. Better results from these holes included: 8m @ 7.14 g/t Au from 82m including 1m @ 21.10 g/t Au from 82m in FKGRC010; 4m @ 7.44 g/t Au from 92m in FKGRC011 and 3m @ 10.70 g/t Au from 69m including 1m @ 23.10 g/t Au from 69m in FKGRC012. This new position is totally open along strike and down dip. Previous explorers in the area have assumed that the granite surrounding deposits/prospects is barren. The discovery of granite-hosted gold at Kat Gap is significant as the same geological setting may be repeated elsewhere throughout Classic's significant >500km2 landholding. Classic will continue to track this unexpected high-grade granite-hosted gold mineralisation in its upcoming drill program at Kat Gap and elsewhere throughout the project area.

    Historical RC drilling is currently on 100m - 200m line spacings. There is strong potential for additional mineralisation to be identified up-dip, down-dip and along strike, both outside of and within the existing RC drill coverage. Only about half of the 5 km long >50 ppb Au gold-in-soil anomaly has been tested by RC drilling along the granite/greenstone contact.

    There is a further 5 km of strike of prospective granite-greenstone contact along-strike from the Kat Gap zone within E74/467 that has seen little or no exploration.

    Classic has already planned follow up drill holes at Kat Gap to be commenced in September and has mobilised the drill rig to Lady Lila and Lady Magdalene for the remainder of this current campaign so there should be steady news flow for the coming weeks/months.


    The FGP Tenements (excluding Kat Gap and Lady Lila) are registered in the name of Reed Exploration Pty Ltd, a wholly owned subsidiary of ASX listed Hannans Ltd (ASX:HNR). Classic has acquired 80% of the gold rights on the FGP Tenements from a third party, whilst Hannans has maintained its 20% interest in the gold rights. For the avoidance of doubt Classic Ltd owns a 100% interest in non-gold rights on the Kat Gap and Lady Lila Tenements including but not limited to nickel, lithium and other metals.

    The FGP contains an existing Mineral Resource of 5.3 Mt at 1.39 g/t for 240,000 ounces of gold, classified and reported in accordance with the JORC Code (2012), with a recent Scoping Study (see ASX Announcement released 2nd May 2017) suggesting both the technical and financial viability of the project. The current post-mining Mineral Resource for Lady Ada, Lady Magdalene and Lady Lila is tabulated below (see link below).

    Additional technical detail on the Mineral Resource estimation is provided, further in the text below (see link below) and in the JORC Table 1 as attached to ASX announcements dated 14th March 2017 and 21st March 2017.

    To view tables and figures, please visit:

    Classic Minerals Ltd
    T: +61-8-6305-0221

    0 0

    PlayChip, the Universal Gaming Token, is cementing its status as one of the most promising token sales of 2018. The PlayChip Foundation, whose token is in pre-sale until October 31, today announced that its combined user count has hit 1 million, a milestone they had initially forecasted surpassing in December.

    The PlayChip Ecosystem's one million users are located across over 70 countries, with particularly high traction in India, Australia, United Kingdom, and USA. When the blockchain-enable platform goes live on December 19, each of these users will be able to easily participate in seven different online gaming platforms that include sports betting, casino games, eSports and Daily Fantasy Sports.

    The success of the PlayChip is indicative of a new trend of reverse ICOs in the cryptocurrency market. Reverse-ICOs refers to existing businesses who tokenize the economy of their user base, unlike traditional token offerings that generally lack a working product and users. Following the success of the Telegram ICO, the PlayChip represents one of the first in this new wave of reverse token offerings.

    "PlayChip is truly a unique token offering because while others write white papers about potential audiences and hypothetical use cases, PlayChip is well positioned with a very active global audience on multiple platforms that are already part of the PlayChip family," Luke Lombe, Head of Blockchain with PlayChip said.

    "The team at PlayChip are thrilled about hitting the million-user mark earlier than expected, and we look forward to continued strong growth. We are in the middle of our pre-sale and very much focussed on delivering a quality product that surpasses the expectations of our loyal following."

    The seven gaming platforms in the PlayChip ecosystem include PlayUp, DraftStars, Betting.Club, ClassicBet, TopBetta, MadBookie, and 123Bet. All players will be able to seamlessly move between platforms via the integrated PlayWallet and instantly cash out via the PlayXchange. In FY2018, these platforms are on track to exceed a turnover of US$430 million.

    For more information, please visit:
    or read the PlayChip Whitepaper:

    About PlayChip

    PlayChip is the Universal Gaming Token for sports betting, gaming, fantasy sports, and eSports, at the centre of an incentivised, blockchain-enabled sports community and gaming ecosystem. The PlayChip Ecosystem consists of seven independent partner platforms with more than a million users across over 70 countries. The PlayChip ecosystem is designed to be secure, scalable, simple to use, and fun, as well as include features to incorporate provable fairness into PlayChip transactions and the partnered gaming platforms, making it the gaming token of choice around the globe.

    For editorial enquiries for PlayUp please contact 
    Michael Henderson
    DEC PR 
    Phone +61 413 054 738

    0 0

    Lithium Power International Limited (ASX:LPI) (OTCMKTS:LTHHF) ("LPI" or "the Company") is pleased to confirm it has finalised the acquisition of an additional 1% interest in the Maricunga Lithium Brine Project in Chile, bringing its interest to 51% as previously announced. The cost was ~AU$1.5 million, paid from current cash reserves.


    - LPI acquires an additional 1% of the Chilean Joint Venture Company, Minera Salar Blanco S.A., ("MSB") to now hold 51%

    - Key MSB staff and contractors issued 1.8m LPI shares for services over the past two years

    - Two new Chilean Directors appointed to LPI's Board

    Together, LPI and its joint venture partner Bearing acquired a total 1.35% from the third joint venture partner, Minera Salar Blanco SpA, ("Minera Blanco"), a private Chilean company owned by Mr Martin Borda.

    LPI and Bearing acquired their additional shareholdings in the Maricunga joint venture company, Minera Salar Blanco S.A. ("MSB"), through a pro rata of the overall shareholding in MSB.

    The ownership of the project is now LPI 51%, Minera Blanco 30.98% and Bearing 18.02%.

    To further align LPI's interests with MSB and cement the strong connection between the two groups, the joint venture Board has approved the issue of 1.8m fully paid LPI shares to seven key MSB staff and contractors. These people have been important in the delivery of the key milestones associated with the project over the past two years. These shares will be issued under ASX Listing Rule 7.1.

    LPI is to add two new Directors to its Board to further enhance its relationship with MSB. They are Mr Martin Borda, owner of the Chilean joint venture partner, Minera Blanco, which owns 30.98% of MSB, and Mr Cristobal Garcia-Huidobro, Chief Executive Officer of MSB.

    LPI's current Chile based Director, Dr Luis Ignacio Silva, a Director at the time of the Company's IPO, retires from the Board.

    These Board changes are to take effect from Monday 3 September 2018.

    LPI 's Chairman, David Hannon, said:

    "The completion of the 1% acquisition of MSB gives LPI 51% of the Maricunga project in Chile and further cements our relationship. The Joint Venture continues to strengthen as we move towards the development of one of the highest quality pre-production lithium brine projects globally. Rewarding key personnel in Chile with LPI shares demonstrates our ongoing commitment. We are also delighted to welcome Mr Borda and Mr Garcia-Huidobro to the LPI board, which will strengthen the Australian- Chilean connection. I would also like to thank Dr Silva for his service to the Company during the past 3 1/2 years, both prior and since the Company's IPO."

    David R Hannon - Chairman or 
    Andrew Phillips - Company Secretary
    Lithium Power International
    Ph: +61-2-9276-1245
    Twitter: @LithiumPowerLPI

    0 0

    Carnarvon Petroleum Limited (ASX:CVN) (OTCMKTS:CVONF) provides the Company's shareholder update.

    Letter to shareholders

    Dear Fellow Shareholder,

    Given the activity around and focus on our drilling results, it is timely to present and remind shareholders of the broader context and value proposition of the Company. To this end we have prepared and attach a succinct Shareholder Update for your consideration.

    The Dorado discovery is the break through result Carnarvon was seeking. It is a large and exciting outcome that is expected to be central to the commercialisation of the oil and gas resources in this region.

    The Dorado discovery also proves a play type that has a number of follow on targets to consider. We're refining these and look forward to presenting them to you shortly.

    Santos recently announced their proposed acquisition of Quadrant Energy. We welcome them to the joint venture and look forward to working with their team, whom we know well.

    We expect to be considering our forward program and development options around Dorado very soon. We're clearly keen to advance this work and intend to provide you with regular progress updates.

    While the Dorado and Phoenix South wells have been the focus recently, our team has also been advancing our 100% held Buffalo oil field redevelopment project.

    A central piece to this is the progression of the new Production Sharing Contract. Teams from Carnarvon and the Australian and Timor-Leste Governments have been working diligently on this task and appear to be making solid progress.

    In addition to keeping you all informed of our progress across each of our projects, I also look forward to meeting as many of you as I am able, especially at our Annual General Meeting in November.

    To view Shareholder Update Presentation, please visit:

    Investor inquiries:
    Thomson Naude
    Company Secretary
    Phone: +61-8-9321-2665
    Media inquiries:
    Luke Derbyshire
    Managing Director, Spoke Corporate
    Phone: +61-413-809-404

    0 0

    Following the decision by Newmont Tanami Pty Ltd (Newmont) (a wholly owned subsidiary of Newmont Mining Corporation) to form a joint venture with Nova Minerals Limited (Nova or Company) (ASX:NVA) (FRA:QM3) in relation to the Officer Hill Gold Project (Project), the directors of Nova are pleased to provide details of the proposed exploration program for the remainder of 2018.

    The Officer Hill Project on EL23150 covers 206km2 and is located 34km south west of the Callie deposit which is part of Newmont's Tanami Operations. The exploration program is targeting Callie-style mineralisation within EL23150.

    Newmont has successfully completed its sole funding commitments pursuant to the terms of the Officer Hill Joint Venture Agreement. Newmont has earned a 70% interest in EL23150 whilst Nova retains a 30% interest in the tenement. The operating committee for the Project has approved exploration activities including follow up diamond drilling (see Figure 1 in link below), an airborne gravity gradiometry survey and follow up geochemistry around the Paris prospect in the western portion of EL23150. The Paris prospect was identified in 2017 using Newmont's Proprietary Deep Sensing Geochemistry (DSG) (Table 1).

    Approvals have been received for the current Mining Management Plan and an Exploration Works Program submitted to DPIR and the Central Land Council respectively. Newmont is responsible for managing the Project.

    Table 1: Program and activities approved
    Proposed Program 2018 (H2)                          Units 
    DSG Infill samples at Paris Prospect (Phase 1)      249  
    Airborne Gravity Gradiometry (CGG) (Phase 1)
    Diamond Drilling                                    4,100m 
    3x 700m (Phase 1)                                   2,100m 
    2x 1,000m Phase 2)                                  2,000m  

    NVA Managing Director, Mr. Avi Kimelman said:

    "We are excited with the commencement of the Joint Venture and approval of the program as it is the first major step in advancing the Officer Hill Gold Project. This is an exciting phase for Nova across the project as it is located within the ~13 million ounce Tanami endowment and within close proximity to Newmont's Tanami Gold Mine".

    "Newmont's involvement brings valuable technical expertise and insights to the Project, and provides further endorsement of Nova's exploration package at the Officer Hill gold project."

    "Concurrent with Officer Hill exploration program, Nova is fast tracking its Estelle Gold Copper project exploration and development activities in Alaska and Thomson brothers lithium project operations and corporate development strategy which will deliver a parallel approach to enhance shareholder value across our company's project portfolio as quickly as possible."

    To view tables and figures, please visit:

    Nova Minerals Ltd
    P: +61-3-9614-0600
    F: +61-3-9614-0550

    0 0

    Anti-counterfeit and customer engagement solutions provider YPB Group Ltd (ASX:YPB) is pleased to announce that its channel partner in the legal cannabis industry, Namaste Technologies (CVE:N), has released its recreational cannabis market strategy to the TSX Venture Exchange.

    - Partner Namaste launches recreational market strategy

    - Cannabis confirmed powered by YPB integral to plan

    - Global legal market size expected to reach USD 146.4 billion by end of 2025

    YPB is integral to Namaste's plans and the move into recreational cannabis by Namaste magnifies the opportunity for YPB. The U.S. legal marijuana market size was estimated at USD 7.06 billion in 2016 and is expected to grow at a CAGR of 24.9% from 2017 to 2025(see Note below). Medical marijuana was the largest marijuana type segment in 2016 and is estimated to be valued at USD 100.03 billion by 2025(see Note below).

    Namaste is a global leader in the sale of all elements of medical cannabis consumption and aspires to become the world's "one stop shop" of the cannabis industry. Namaste has nine offices with multiple distribution centres around the globe and operates 32 websites under various brands in 20 countries. Namaste's e-commerce sites have over 600,000 monthly visits and a database of 1.5 million users and are growing rapidly. Its market capitalisation is approximately CND500 million.

    In Canada, Namaste has built a fully integrated e-commerce hub whereby patients can be seamlessly connected to doctors and a range of high quality cannabis products, cannabis cultivators (both domestic and international), cannabis brands and cannabis consumption systems. Namaste will now extend this capability into the recreational cannabis market which is expected to be legalised by the Canadian Federal Parliament in October 2018. Namaste's ambition is to become the Amazon of cannabis, the central hub in a well controlled, safe environment that aids regulators in keeping the cannabis supply chain free of criminal elements.

    Central to Namaste's strategy is ensuring the integrity of the whole industry from producers to consumers and regulators. The core of Namaste's integrity drive is offering certainty of authenticity to consumers, including provenance visibility and supply chain security, and to allow producers to engage closely with their consumers. To that end YPB and Namaste recently launched Cannabis Confirmed which is driving to become the global standard for cannabis authenticity and supply chain integrity. YPB's solutions provide the technology backbone and Namaste brings unparalleled market access. (

    The scope of the opportunity and the centrality of YPB to Namaste's ambitions is best conveyed to shareholders via the following extracts from Namaste's release:

    ..... Namaste is extremely confident that many of its technology assets will lend themselves to improving the security and distribution of recreational cannabis online and in provincially operated dispensaries. Namaste's platforms, including its exclusive partnership with YPB Group Ltd. ("YPB") (ASX:YPB), have the potential to provide far superior authentication and security for provincially approved cannabis products. In addition, the Company's age and identity verification, with exclusive rights to its facial recognition technology, could help provide a much safer protocol for online retail platforms.

    ..... Namaste has also identified the need for its global customers to have confidence in the products they are purchasing, and for vendors to have access to granular data on their end-users. As such, Namaste has introduced YPB's solutions across its network of manufacturers, including Canadian Licensed Producers, to help bring certainty of authenticity and supply chain transparency to the entire legal cannabis industry globally. This coalition furthers Namaste's agenda in providing leading technology platforms for its global marketplace and for enhancing the user experience for its customers.

    ..... there is little doubt that this technology brings value to those who adopt YPB's technology. Namaste believes YPB's technology could provide a far superior solution to all provinces, especially considering the Ontario Provincial Governments decision regarding online dispensaries. The use of product QR codes would allow those who adopt the technology the ability to not only verify the authenticity of a cannabis product being provincially approved, but also provide valuable product information, including strain data and origin.

    Namaste will be initiating the development of a private-label line of cannabis products through its Licensed Producer partners that will include a unique offering of premium strains and products that will be targeted to both medical and recreational markets. By securing numerous agreements with a multitude of Licensed Producers, Namaste has successfully guaranteed its supply channel on a going forward basis, and pending approval of Cannmart's sales license, the Company is well positioned to launch its fully-integrated marketplace by introducing cannabis sales into its online platform.

    The Company will be actively pursuing opportunities in online recreational cannabis sales within provinces that permit. Through its partnerships with Licensed Producers, Namaste will offer a comprehensive online platform for recreational cannabis including integration of its various technology components that will bring significant value to Namaste and its partners.

    YPB's Executive Chairman John Houston said: "We are working very actively with Namaste to secure the vacant position of authentication standard for the cannabis industry. Given Namaste's reach into all significant legal, or pending legal, cannabis markets the opportunity for YPB is genuinely global. Namaste is a dynamic group and together we are moving rapidly to capture centre stage and the very significant opportunity in the burgeoning legal cannabis market."


    Source: Legal Marijuana Market Size, Share & Trends Analysis Report By Type, By Product Type, By Medical Application And Segment Forecasts, 2018 - 2025

    About Namaste Technologies

    Listed on the TSX Venture Exchange and headquartered in Vancouver, Canada, Namaste is a global leader in the sale of all elements of medical cannabis consumption and aspires to become the world's "one stop shop" of the industry. Namaste has nine offices with multiple distribution centres around the globe and operates 32 websites under various brands in 20 countries.

    Mr. John Houston 
    Executive Chairman
    YPB Group Limited
    Mr. Gerard Eakin
    YPB Group Limited

    0 0

    Donaco International Limited (ASX:DNA) has announced its results for the financial year ended 30 June 2018 (FY 18).

    Result Summary

    - The statutory loss of A$124.5 million includes the previously announced A$143.9 million non-cash impairment charge in the value of the Star Vegas casino license, following the vendor's breaches of contract

    - Underlying net profit for the group was $18.3 million before non-recurring items

    - Management has been effective in rebuilding the Star Vegas business:

    o Five new VIP junkets signed up, to replace those poached by the Thai vendor

    o VIP turnover up by 54% in the June half, compared to the December half

    o Significant improvements in non-gaming amenities

    o New slot machine and casino management system going live

    - Donaco announces today the launch of its online gaming business at Star Vegas

    o Expected to become a significant revenue contributor as the business grows

    - Donaco's financial position remains solid

    o Positive operating cash flow of A$34.6 million (A$47.4 million in pcp)

    o Ongoing debt reduction with net debt down to A$22.1 million from A$42.5 million

    o Further repayment of USD8.6 million in August 2018 has reduced Mega Bank debt to USD40 million

    - Star Vegas operating performance declined significantly due to the breach of non-compete clauses by the Thai vendor, which harmed the VIP business

    o Gaming revenue fell 42% primarily due to decline in VIP business

    o Despite a slight increase in main floor visitation main floor spending remained subdued due to weak domestic demand in Thailand

    o Junket commissions reduced by 48% in the period due to lower VIP turnover

    o Operating Expenses down 11% reflecting more efficient management

    o Property level EBITDA down 54%, reflecting lower VIP turnover

    o Normalised EBITDA down 38%, after adjusting for win rates

    - Aristo continues to perform solidly with revenues maintained and costs controlled

    o VIP turnover up 46%, with lower win rate than the pcp

    o Net profit after tax up 19%

    Donaco has reported a net loss after tax of A$124.5 million for the 2018 financial year, including the previously advised non-cash impairment charge of A$143.9 million in the value of the Star Vegas casino licence. The results are consistent with the trading update provided in April.

    The group recorded a reported EBITDA of A$42.4 million (A$65.3 million in pcp) and generated an Underlying NPAT of $18.3 million (A$54.6 million in pcp).

    Group revenue declined to A$92.6 million from A$136.4 million previously due to the reduction in VIP business at Star Vegas, following the breach of non-compete clauses by the Thai vendor.

    Operational Performance

    Commenting on the FY18 result, Donaco CEO Mr Joey Lim said:

    "Although the year has presented its challenges, operationally we have taken full control of the Star Vegas casino and have introduced new facilities, new junkets and launched our online gaming operations. Star Vegas did suffer a significant drop in its VIP turnover as a consequence of the breaches of non-compete clauses by the vendor. Aristo has continued to perform solidly despite a lower win rate than last year. We have also efficiently managed the cost base, and despite the challenges, both venues have operated profitably. However, our reported financials show the impact of the A$144 million impairment charge. We are aggressively pursuing legal action against the Star Vegas vendor and seeking USD190 million in damages to remedy the impact on our business.

    "We were presented with some significant challenges at Star Vegas with the vendor illegally operating two competing casinos and poaching our Thai junkets, which had a significant impact on the full year result. The performance of our VIP business at Star Vegas was particularly impacted in the early part of the financial year, but we have worked hard to restore the junket business. Pleasingly, we have seen the second half producing a significant uplift in VIP turnover, which has continued to improve into the current financial year.

    "Star Vegas did show a pick up in patronage on the main floor, however the subdued backdrop of the Thai economy continued to hold back the main floor revenues. We are seeing encouraging signs from the initiatives we have taken to drive main floor revenues, including new gaming machines, upgraded facilities, and a second main floor targeting non-Thai players.

    "We are also excited by the launch of our online gaming business at Star Vegas which should provide us with medium term growth in revenue and profits.

    "At Aristo our underlying performance was solid, with our VIP turnover increasing by 46% over the year, albeit with a lower win rate. Our non-gaming revenue continued to improve to now make up 46% of the revenue base at the property.

    "Our group balance sheet remains strong, with our debt to equity reducing to 6.0% at the end of June, and a further principal repayment of USD8.6 million made in August. However, we have had to hold off on further dividend and buy-back initiatives until the reported statutory profit is restored".

    Update on Legal Matters

    As previously announced, the Company has commenced legal proceedings against the Star Vegas vendor to enforce its legal rights and receive financial compensation for the losses incurred.

    On 25 December 2017 Donaco obtained an injunction ordering the closure of the Star Paradise and Star Paramax casinos, which were illegally operated by the vendor of the Star Vegas business. Both casinos were operating without licences, and in breach of non-compete agreements. After the injunction was obtained, Star Paradise changed its name to "Winsor", and continues to operate. The vendor's initial arguments against the injunction were rejected by the Cambodian court. The vendor has made a further appeal to a higher court, but there is no progress with this appeal.

    On 29 March 2018 Donaco obtained a freezing order on the vendor's DNA shares from the NSW Supreme Court, and the order has now been extended until 2 November 2018.

    On 6 July 2018 the vendor made claim for security rights over certain assets of Star Vegas, relating to his claim for the unpaid FY17 management fee, which was rejected by the Cambodian court. Three days later, a different firm of lawyers acting for the vendor filed an essentially identical claim. Donaco has argued that this is an abuse of process, and should also be rejected.

    Donaco obtained an injunction to prevent the vendor's threatened termination of the Star Vegas lease. The vendor has now commenced arbitration proceedings in Cambodia, which are in early stages and Donaco is hopeful of a positive resolution of this matter within the next six months.

    The vendor has commenced defamation proceedings in Thailand against Donaco and two of its directors, seeking damages of THB1 million (approx. $41,000). The claim relates to Donaco's ASX releases, which Donaco is legally required to issue.

    Donaco has commenced arbitration proceedings in Singapore with a claim for USD190m relating to the vendor's breaches of the sale agreements for Star Vegas. Due to unavailability of lawyers and the arbitrator, the hearing date is currently set for 29 July 2019, despite Donaco's best efforts to obtain an earlier hearing date.

    Donaco will provide updates on these matters as they are develop and are resolved.

    Property Performances

    Star Vegas

    - Net Gaming Revenue down 44.7% to THB 1,519.7 million

    - Non-Gaming Revenue up 2.7% to THB 153.3 million

    - EBITDA down 53.9% to THB 971.1 million

    - Normalised EBITDA down 38.2% to THB 901.3 million

    - VIP Gross Win rate 3.00% compared to 3.54% in pcp

    Donaco CEO Joey Lim said:

    "Our management team has been focused on rebuilding the Star Vegas business, following the disruptions caused by the vendor's contract breach. During FY18 we signed up five new junkets to replace those lost in the management transition, consequently VIP turnover in the June half improved by 54% on the December half and we are encouraged by strong turnover experienced in August 2018. We also have an agreement in principle with a Chinese tour group operator to fill a second main hall, with new tour groups expected to commence from September. We reinvigorated our slot machine inventory during the year, which we expect to increase revenue during FY19.

    "We originally engaged Vivo Tower to fill unused space at star Vegas, by marketing it to non-Thai junket operators and players, and to bring in tenants to operate non-gaming facilities. Following the breach of the sale agreement by the Thai vendor, Vivo was re-directed to bring in new Thai junkets. Now that Donaco has taken full operational control of Star Vegas, the contract with Vivo has been terminated. Donaco will receive direct rental payments from tenants brought in by Vivo, which will substantially replace the fixed fee previously payable by Vivo. Under a new agreement, Vivo have now been engaged to market and manage the Donaco online gaming platform, for a revenue share.

    "Online gaming operations have launched, with an advanced software platform that has been optimized for both mobile and desktop devices. The platform has a live dealer casino and sportsbook, supports multiple languages and currencies, and will be offered to downstream partners, who will market to their own customer bases."

    Aristo International Hotel

    - Net Gaming Revenue down 10.8% to RMB 71.4 million

    - Non-Gaming Revenue up 12.7% to RMB 60.4 million

    - EBITDA down 4.1% to RMB 71.8 million

    - VIP Gross Win rate 1.91%, compared to 2.28% in pcp

    Commenting on the performance at Aristo, CEO Joey Lim said:

    "We were pleased with Aristo's performance, with the property level NPAT growing by 19% on last year, assisted by lower finance costs and depreciation & amortisation. Whilst the property level EBITDA fell 4% to RMB 71.8 million due to the lower win rate, the normalised EBITDA, using the theoretical win-rate, improved by 37.8% to RMB 151.3 million. Our VIP turnover improved significantly and our non-gaming revenue continued to grow. In constant currency our turnover increased by 46%, as we selectively allowed new VIP junkets into the property. Overall revenues slightly reduced, with net gaming revenue 10.8% below last year entirely attributed to the lower win rate of 1.9%, compared to 2.3% in FY17. Visitation was down 12% compared to last year, but this was due to the cancelling of a marketing initiative which was not meeting our objectives. Despite this, slot machine revenue was only down slightly and non-gaming revenue increased by 12.7%, to now make up 46% of total revenue, reflecting initiatives put in place to diversify the business."

    Outlook for FY19

    Mr Lim concluded, "We are continuing to rebuild and improve the Star Vegas business, with multiple initiatives in progress. Over the medium term we expect to drive growth from the newly launched online gaming platform, new Chinese mass market tour groups, and improved slot machines and systems. In relation to Aristo, we are aiming to further increase the number of mass market players visiting the property, and will selectively allow junket play when appropriate. At both venues we are focused on growing non-gaming revenues to diversify earnings streams.

    "There are multiple legal actions in progress involving the Star Vegas vendor and we believe our position is strong, as shown by favourable court decisions issued to date. There is an injunction in force which prevents the vendor's attempt to terminate the Star Vegas lease and we are hopeful of a positive resolution of this matter within the next six months. The arbitration in Singapore for the USD190 million damages claim is likely to exceed 12 months, with a hearing due to commence on 29 July 2019.

    "In relation to capital management, we have been focused on reducing Mega Bank debt, which has fallen to USD40 million, following a repaying of USD8.6 million made in August 2018. Due to the impairment charge there will be no FY18 dividend payable, as dividends are restricted to 100% of NPAT, and any extension of the current buyback will require approval from Mega Bank.

    "Overall we do expect to see significantly improved performance at Star Vegas, further improvement at Aristo, and a strong return to reported profitability at group level."

    To view Investor Presentation, please visit:

    Donaco International Ltd
    Ben Reichel 
    Executive Director
    T: +61-412-060-281

    0 0

    Rumble Resources Ltd (ASX:RTR) ("Rumble" or "the Company") is pleased to announce that RC drilling assays have been received from the recent Munarra Gully Cu-Au projects maiden drill program which consisted of seven (7) RC holes for 1149m. The Munarra Gully project is located some 50km NNE of the town of Cue within the Murchison Goldfields.

    Very significant copper-gold RC drill intercepts discovered in fine to medium grain orthopyroxenitic rocks, potentially represents a style of magmatic sulphide mineralisation that is known to host large copper systems in Brazil and South Africa.

    Lag and grab sampling by Rumble has outlined over 8km of strike potential coinciding with a partly buried strong magnetic anomaly which has been inferred as the same host - orthopyroxenite.

    Munarra Gully - M51-0122 - White Rose Prospect - Cu-Au Discovery

    Significant disseminated sulphide mineralisation in mafic intrusive rocks at the White Rose Prospect has returned:

    - 22m @ 1% Cu from 29m coincident with 19m @ 2.19 g/t Au from 33m (WRRC001).

    o Co-incident copper - gold mineralisation within orthopyroxenites includes 10m @ 3.41 g/t Au from 40m (maximum Au value 11.56 g/t) in WRRC001.

    - All four RC drill-holes (two lines, 160m apart) completed at the White Rose Prospect returned strong copper-gold sulphide mineralisation in both oxide and primary zones. Other intercepts include:

    o Co-incident copper - gold mineralisation - 10m @ 0.74% Cu from 75m with 11m @ 0.73 g/t Au from 75m (WRRC002).

    o Co-incident copper - gold mineralisation - 26m @ 0.79% Cu from surface and 7m @ 0.64% Cu from 28m with 5m @ 1.17 g/t Au from 13m, 5m @ 0.71 g/t Au from 20m and 9m @ 1.64 g/t Au from 27m (WRRC003).

    Potential Mafic Hosted Magmatic Sulphide System

    - Copper and gold sulphide mineralisation associated with fine to medium grain undifferentiated orthopyroxenite/norite intrusive (mafic/ultramafic) rocks.

    - Copper and gold are associated with chalcopyrite and bornite. The mineralisation has very high Cu:Ni ratios with strong silver anomalism (to 11.4 g/t Ag). Platinum group elements assay results are pending.

    - The style of mineralisation has similar characteristics to known large copper rich mafic intrusive (ortho-pyroxenite) deposits in Brazil (Caraiba mining district - 96Mt @1.82% Cu reserve and historic production) and South Africa (Okiep mining district - Koperberg - 94Mt @ 1.75% Cu historic production). Gold, silver and PGM's are associated with these copper deposits (further detail page 5).

    Lag Sampling highlights Mafic Hosted Cu-Au Sulphide Potential

    - Lag (soil) sampling by Rumble has highlighted strong copper anomalism over 3.5km strike 4km to the southwest of the White Rose Prospect. Copper in lag anomalism (>400 ppm Cu) is supported by strongly anomalous Cu - Au grab sampling (Cu to 0.28% and Au to 2.11 g/t - no previous exploration or workings).

    Rumble's Technical Director, Mr Brett Keillor, said "to have a significant copper-gold discovery with Rumble's maiden RC drilling programme at Munarra Gully is exceptional.

    Discovering the copper-gold association with disseminated sulphides highlights the potential for economic copper-gold bearing mafic/ultramafic intrusive related mineralised systems. The mineralisation style bears close resemblance to known atypical magmatic sulphide systems worldwide where large world class copper (gold) deposits have been historically mined - the Caraiba Cu province in Brazil and the Okiep Cu province in South Africa are examples.

    Within the Munarra Gully Project, Rumble has only tested a small section of a potential Cu - Au bearing intrusive system. Limited soil geochemistry and aero-magnetic interpretation has identified up to 8km of strike potential. Lag (soil) sampling over areas of less cover has highlighted 3.5km of significant copper anomalism.

    The Munarra Gully project has all year round access and is close to major infrastructure and represents a potential discovery and Rumble will fast track systematic exploration to delineate first order copper-gold drill targets."

    White Rose Cu-Au Prospect - New Cu-Au Discovery

    Four (4) drill-holes (WRRC-001 to WRRC-004) were designed to test the primary zone below two small open cuts at the main White Rose Prospect. Two traverses, 160m apart were completed. Widespread copper and gold mineralisation in oxidised ultramafic/mafic had been exposed in the open cuts by the current owner. The open cuts (active operation) have a maximum depth of nearly 20m. Historic RAB drilling focused on gold and was confined to shallow oxide (vertical depth of 32m).

    All drill-holes (four completed on the White Rose Prospect) intercepted widespread significant copper- gold mineralisation. See Images 2 and 3 in link below for sections.

    - Copper and gold are associated with disseminated sulphide (chalcopyrite and bornite) mineralisation hosted in orthopyroxenite (norite) intrusive. RC drilling intercepts include:

    o * WRRC001 - 22m @ 1% Cu from 29m coincident with 19m @ 2.19 g/t Au from 33m. Maximum Cu was 2.66% (40-41m). Maximum Au was 11.56 g/t (49-50m).

    o * WRRC002 - 10m @ 0.74% Cu from 75m coincident with 11m @ 0.73 g/t Au from 75m.

    o * WRRC003 - 26m @ 0.79% Cu from surface and 7m @ 0.64% Cu from 28m. In addition, 5m @ 1.17 g/t Au from 13m, 5m @ 0.71 g/t Au from 20m and 9m @ 1.64 g/t Au from 27m.

    o * WRRC004 - 23m @ 0.54% Cu from 45m and 6m @ 0.66% Cu from 70m.

    * 0.3% Cu and 0.3 g/t Au lower cut-off and true intercept width unknown

    Approximately 160m to the west of the White Rose Prospect a single RC hole (WRRC007) tested the inferred strike of the copper-gold mineralisation. The hole intercepted a late dolerite dyke which has intruded into the prospective zone thereby displacing the inferred mineralisation (see image 1 in link below).

    The disseminate sulphide mineralisation at White Rose is hosted in generally fine grain undifferentiated orthopyroxenite/norite to dolerite rock types. The rocks are magnetite bearing. Ag is strongly elevated (to 11.4 g/t Ag). PGE (platinum group elements) assay results are pending. The higher order copper-gold mineralisation lies within the mafic rocks immediately adjacent to the contact with ultramafic (>10% Mg) rocks.

    The deposition style is considered very significant as it potentially represents copper bearing mafic/ultramafic intrusive related mineralisation. Examples include the Caraiba Cu mining district in Brazil (production and reserve - 96Mt @ 1.82% Cu) and the Okiep (Koperberg) Cu mining district in South Africa (historic production - 94Mt @ 1.75% Cu) - see overview section below.

    Regional Geochemistry - E51/1677 (see image 4 in link below)

    Rumble has conducted limited (400m by 100m spacing) lag geochemistry along the inferred mafic/ultramafic lithological horizon with additional grab sampling within E51/1677. The area is located 4km southwest of the White Rose Prospect. Lag sampling (107 samples taken) returned significant copper, nickel and gold anomalism. Copper returned up to 721 ppm in lag, nickel to 1800 ppm and Au to 72 ppb.

    Copper anomalism over 3.5km in strike coincided with inferred mafic/ultramafic (orthopyroxenites) from aero- magnetics. Grab sampling along the copper in lag anomalism (only 3 samples collected) returned up to 2.11 g/t Au and 0.28% Cu. There were no previous exploration or historic workings associated with the grab sampling.

    Large First Order Conductor (see image 1 in link below)

    Two (2) holes were completed. The target is a large conductive plate (470m by 260m) that lies 600m west of the White Rose prospect. The first hole (WRRC-005 - 200m depth) missed the target due to the presence of a late dolerite dyke. The hole lifted from 70deg to 45deg and the azimuth moved 20deg.

    The second hole (WRRC-006 - 289m depth) was completed by a larger capacity rig and was able to stay within tolerance with respect to intercepting the modelled conductor. Due to a blockage, the down-hole TEM survey (completed 25th August) was tested to 250m (down-hole depth). Results pending.

    Overview of Mafic Intrusive Hosted Copper (Au, PGM) Sulphide Deposits (see References 1, 2, 3, 4 below)

    In the Caraiba Complex, Bahia Province, Brazil, numerous mafic/ultramafic irregular shaped intrusions hosted chalcopyrite-bornite mineralisation (predominantly in orthopyroxenite). The total reserve for the complex (including historical production) is estimated at 96 Mt @ 1.82% Cu. The deposits are atypical of magmatic deposits in that magnetite may be up to 50%. The copper mineralisation is typically 70% chalcopyrite: 30% bornite. In addition, very high Cu:Ni ratios are the norm with associated Au, Ag and PGM's. Gold is reported to 22 g/t. The copper bearing intrusives are hosted in amphibolite/granulite rocks (ultra-high temperature metamorphics).

    A similar style of copper mineralisation has been mined in the Okiep mining province in South Africa (Koperberg suite). Historically some 94 Mt @ 1.75% Cu was mined from predominantly orthopyroxenites associated with numerous irregular shaped mafic to ultramafic bodies with characteristic high Cu:Ni ratios and very strongly anomalous Au, Ag and PGM's.

    Next Steps

    Fast tracking exploration on the significant new Cu-Au discovery will involve:

    - PGM assays - results are pending.

    - DHEM - awaiting modelling and interpretation results.

    Further surface geochemistry, geophysics and drilling will be conducted based on methodologies determined suitable by the above criteria.


    1. Maier, Wolfgang & Barnes, Sarah-Jane. (1999). The origin of Cu sulfide deposits in the Curaca Valley, Bahia, Brazil: Evidence from Cu, Ni, Se, and platinum-group element concentrations. Economic Geology. 94. 165-183. 10.2113/gsecongeo.94.2.165.

    2. Cawthorn R G, Meyer F M 1993 - Petrochemistry of the Okiep Copper district basic intrusive bodies, Northwestern Cape Province, South Africa: in Econ. Geol. v88 pp 590-605

    3. Lombaard A F, Okiep Copper Company Limited 1986 - The copper deposits of the Okiep district, Namaqualand: in Anhaeusser C R, Maske S, (Eds.), 1986 Mineral Deposits of South Africa Geol. Soc. South Africa, Johannesburg v2 pp 1421-1445

    4. Maier W D 2000 - Platinum-group elements in Cu-sulphide ores at Carolusberg and East Okiep, Namaqualand, South Africa: in Mineralium Deposita v35 pp 422-429

    To view tables and figures, please visit:

    Shane Sikora
    Managing Director
    Phone: +61-8-6555-3980

    0 0

    MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to confirm the lodgement of the MMJ Appendix 4E for the financial year ended 30 June 2018 (as attached to this announcement).

    The 2018 MMJ Annual Report including audited financial statements will be lodged during September 2018.

    The Appendix 4E is also available on MMJ's website:


    The profit for the consolidated entity after providing for income tax and non-controlling interest amounted to $34,119,000 (30 June 2017: loss of $12,725,000).

    On 10 October 2017, MMJ first announced its intention to begin shifting its operational focus toward that of a global cannabis investment company, targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, research & development, hemp food products and retail.

    To view the full report, please visit:

    Investor Enquiries
    Jim Hallam
    Chief Financial Officer and Company Secretary

    0 0

    Australian Securities Exchange and Frankfurt Stock Exchange cross listed iSignthis Ltd (ASX:ISX) (FRA:TA8), the deposit taking EEA authorised monetary financial institution with transactional banking capability (the "Company"), is pleased to announce that it is now a scheme member of the European Payments Council (EPC) Single Euro Payment Area (SEPA) Scheme. Participants in the scheme must first hold relevant regulatory authorisations, of which the Company holds an EEA Authorisation as a deposit taking eMoney Institution.

    The SEPA Scheme allows for:

    - SEPA Direct Debits (customers may 'pull' funds overnight from one EU based bank account to another)

    - SEPA Direct Credits (customer may 'push' funds overnight from one EU based bank account to another)

    - SEPA Direct Business Debits (business to business overnight direct debits from one EU based bank account to another)

    - SEPA Instant Credits (customer may instantly 'push' funds from one EU based bank account to another)

    The Company will issue bank accounts under the International Bank Account Number (IBAN) format, addressable by its Bank Institution Code (BIC) of ISEMCY22. The IBANs will be linked to its central bank account, and all inbound and outbound funds will be via its BIC of ISEMCY22 and the customer specific IBAN issued in customers name.

    The Company will be in a position to issue IBANs to both retail and business customers from the 1st September against its ISEMCY22 BIC, with SEPA fund transfers from/to its central bank based facilities being available mid-November 2018.The Company is investigating means to bring forward scheme certification and operational readiness in advance of November 2018.

    John Karantzis, CEO of iSignthis said, "The ability to issue bank accounts linked an IBAN, that are locatable via our BIC allowing for electronic funds transfer from any SEPA based bank is a significant step forward for the Company. ISXPay will soon be able to link its eMoney Accounts (EMAs) to IBANs and allow for deposits into the IBANs via card payments or SEPA transfers, with international SWIFT transfers to follow. Customers may then keep funds on deposit with iSignthis in their IBAN based account. Retail customers will be AML KYC screened via our patented Paydentity (TM) service, allowing for rapid issue of IBANs, with instant onboarding and full unrestricted account operation. Retail customers may then make instant payments direct to merchants who have EMAs with the Company, and may transfer funds out via SEPA, Original Credit Transfer back to a card or SWIFT transfers in the near future. The service is aimed at providing a means for retail customers to interact with the ISX merchant base with the security of central bank based IBAN accounts, in lieu of pooled customer segregated accounts held with each merchant at the merchant's respective bank."

    The above will lead to new revenue streams for the Company whereby SEPA transfers may be charged at commercial rates. It also opens up opportunity for merchants to direct retail customers to deposit funds with ISXPay, such that funds may be instantly issued and redeemed as eMoney at our participating merchants, with redemption based on the fee of 100-150bps via the EMA.

    iSignthis Ltd
    T: +61-3-8640-0990
    F: +61-3-8640-0953

    0 0

    Australian Securities Exchange and Frankfurt Stock Exchange cross listed iSignthis Ltd (ASX:ISX) (FRA:TA8), the deposit taking EEA authorised monetary financial institution with transactional banking capability (the "Company"), is pleased to announce that it is now a scheme member of the European Payments Council (EPC) Single Euro Payment Area (SEPA) Scheme. Participants in EU based schemes must first hold relevant regulatory authorisations, of which the Company holds an EEA Authorisation as a deposit taking eMoney Institution. The Company is in the process of an ADI class application with APRA for Australia.

    The Company advises that it has been issued the following Bank Institution Codes (BIC):

    - iSignthis eMoney Ltd (Cyprus) : ISEMCY22 > (SWIFT and EEA/EU SEPA Connected)

    - iSignthis eMoney (AU) Pty Ltd : ISEPAU31 > (to be connected to SWIFT and Australian EFT via own BSB Code post BECS membership)

    - iSignthis Ltd : ISIGAU31

    BIC is an international standard for unique identification of financial institutions, and are used as the 'address' to route funds from one bank to another, in particular across borders. In Australia, these are usually associated with international transfers and are sometimes known as 'SWIFT Codes'. Per the Company's announcement earlier today, its ISEMCY22 BIC is now connected to the SEPA framework, allowing banks participating in SEPA to route payments to accounts held with iSignthis using the ISEMCY22 BIC as the address.

    Status of Various Card and Payment Schemes 
    Visa Inc         Australia : 
                     Principal Membership Applied 
                     Currently Tier 2 connected via NAB
                     Europe :  
                     Principal Membership Granted 
                     Tier 1 connection by December 2018
    Mastercard       Australia : 
                     Principal Membership Granted 
                     Currently Tier 2 via NAB / Tier 1 by Mid 2019  
                     Europe : 
                     Principal Membership Granted 
                     Tier 1 connection by December 2018 
    JCB              Australia :  
                     Principal Membership application in progress 
                     Currently Tier 2 via NAB / Tier 1 by Mid 2019 
                     Europe : 
                     Principal Membership Granted 
                     Tier 1 connection online and certified 
    ChinaUnionPay    Australia : 
                     Principal Membership Applied  
                     Tier 3 Connection via partners 
                     Europe : 
                     Principal Membership Applied 
                     Tier 3 Connection via partners 
    Diners/Discover  Australia : 
                     Principal Membership Applied 
                     No network connection at present 
                     Europe : 
                     Principal Membership in progress 
                     No network connection at present 
    AMEX             Australia : 
                     Principal Membership Granted 
                     Currently Tier 2 via NAB / Tier 1 by early 2019 
                     Europe : 
                     Principal Membership in progress 
                     No network connection at present 
    SEPA / BECS      Australia : 
                     BECS Membership application in progress  
                     Currently Tier 2 EFT & BPAY via NAB  
                     Scheme Participant 
                     Tier 1 connection by November 2018 
    SWIFT            Australia : 
                     Participant / BIC Issued 
                     Participant / BIC Issued & connected 
                     Tier 1 connection by December 2018 

    iSignthis Ltd
    T: +61-3-8640-0990
    F: +61-3-8640-0953

    0 0

    The directors of Eon NRG Limited (ASX:E2E) (OTCMKTS:ICRMF) ("Eon NRG" or "the Company") submit their report, together with the financial statements for the half year ended 30 June 2018 as follows:

    Review of Operations

    Following the acquisition of the Borie Oilfield, Wyoming in December 2017, the Company has improved production and optimized the operations in that field. A secondary recovery waterflood program was implemented in the North Borie Field.

    Eon carried out a very successful gas well recompletion at the Silvertip Field in February 2018. This well (35-28) recorded a 60-day IP of 487Mcf/day and has produced in excess of 63 million cubic feet of gas up to 30 June 2018 which has contributed to the overall increased production profile from the Silvertip Field in the first half of 2018.

    Exploration Prospects.

    The Company is actively pursuing oil and gas exploration prospects in the Powder River Basin (PRB), Wyoming. Eon NRG is looking to grow its production and reserves by securing land positions which will support prospects that demonstrate strong economic returns. The process of identifying potential prospects by reviewing existing well data and through negotiation with existing operators in the PRB commenced in H1-18.

    The PRB has become one of the most active oil and gas basins in North America, and has a long history of oil and gas production from more than 4,000' of multi-stacked pay zones. The PRB has seen a significant increase in exploration and production in recent years from large E&P companies including Anadarko Resources, Chesapeake Energy, EOG Resources, Anschutz and Devon Energy through horizontal lateral wells in the unconventional rocks of the Niobrara and Mowry Shale. Operators have also tested horizontal laterals in the conventional sandstones of the Parkman, Sussex, Shannon and Turner with excellent results.

    Eon NRG has identified potential drilling opportunities in the Minnelusa Formation, but it will also target the conventional sandstones of the Parkman, Sussex, Shannon and Turner. Minnelusa prospects are supported by strong economics from wells that have good geological support for the presence of hydrocarbons. Well success rates have improved in recent years with better-quality 3D seismic which allows more accurate identification of drill targets.

    To view the full report, please visit:

    Australia -
    Simon Adams, CFO
    Phone: +61-8-6144-0590
    Mobile: +61-439-845-435
    USA -
    John Whisler, Managing Director
    Phone: +1-720-763-3183
    Twitter: @EonNRG

    0 0

    Your Directors present their report for Regeneus Ltd (ASX:RGS) and its controlled entities (the Group) for the financial year ended 30 June 2018.

    Principal activities

    Regeneus is an ASX-listed clinical-stage regenerative medicine company using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address significant unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

    The company is focused on unlocking value in its clinical-stage human and animal pipeline products through generating positive clinical data, technology development and partnering.

    Review of operations

    During the year, Regeneus achieved significant milestones positioning the Group for future growth including:

    AGC licensing of Progenza

    - AGC Inc. have the exclusive rights to manufacture Progenza for Japan. The ongoing collaboration is progressing well with AGC establishing a cell production facility in Japan

    Progenza human clinical STEP trial published

    - Progenza STEP trial positive results were published in the well-respected Journal of Translational Medicine

    Partnering and technology development

    - Advancing partnering discussions for clinical development and commercialisation of Progenza in Japan

    - Patent allowed for Progenza in US complementing patents in Australia and Japan

    - Progenza granted ATMP status in Europe

    Clinical trials

    - RGSH4K ACTIVATE trial met primary endpoints of safety with promising signs of immune stimulation

    - CryoShot pre-pivotal trial of the allogeneic off-the-shelf stem cells for canine osteoarthritis at University of Pennsylvania continues to be recruited

    - Kvax trial of the autologous canine cancer vaccine for lymphoma at Small Animal Specialist Hospital in Sydney continues to be recruited

    To view the full report, please visit:

    To view FY18 Results and Business Update Presentation, please visit:

    Sandra McIntosh
    Company Secretary and Investor Relations
    T: +61-2-9499-8010

    0 0

    Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, is pleased to provide an overview of its results for the financial year ended 30 June 2018.

    - Significant progress on supporting AGC's future manufacture of Progenza to a commercial scale in Japan

    - Advanced discussions to secure a Japanese partner for the Phase 2 trial of Progenza and its clinical development and commercialisation in Japan

    - Positive results from Phase 1 Safety Trial of Progenza showing safety, pain reduction and disease modification in patients with knee osteoarthritis published in the Journal of Translational Medicine

    - US Patent to be granted for the composition, manufacture and use of Progenza

    - Progenza granted Europe's Advanced Therapy Medicinal Therapy (ATMT) classification, recognising it as a regenerative therapy within European Union's legal and regulatory framework

    - Sygenus delivers positive results in preclinical pain study, showing strong analgesic affect

    - Sygenus gel found to significantly reduce the appearance of acne lesions and significantly lighten the colour and reduce the size of age spots

    - Phase 1 ACTIVATE trial of cancer vaccine immunotherapy technology meets primary endpoints for safety and tolerability with encouraging signs of immune stimulation

    The Company achieved a number of major milestones during the period across its Progenza, Sygenus and RGSH4K technologies, and is poised to secure its next licensing partner for the clinical development and commercialisation of Progenza in Japan.

    Strategic Collaboration with AGC Progresses Towards Manufacturing

    Strong progress has been made establishing the appropriate know-how and processes to support AGC's future manufacture of Progenza under cGMP to a commercial scale. During the period, a cell production facility was established at AGC's Yokohama Research Centre and a knowledgeable team with considerable cell therapy experience recruited. The team is able to successfully replicate the production process for the Australian STEP trial, and is now developing processes to support an increase in manufacturing capabilities to a commercial scale.

    Discussions Well Advanced with Several Potential Japanese Clinical and Commercialisation Partners

    Management is in the advanced stages of discussion and due diligence processes with potential licensees for the clinical development and commercialisation of Progenza in Japan. Working closely with AGC and the Company's Japanese advisors, it is anticipated that a licence agreement will be secured in Q2 FY19. The licensee will be responsible for the sponsorship and funding of the Company's Phase 2 trial of Progenza for osteoarthritis and its commercialisation in Japan and will mark a significant next milestone in the Company's progress towards commercialisation.

    Positive Progenza Phase 1 Safety Trial Published in Journal of Translational Medicine

    The Phase 1 Safety, Tolerability and Efficacy of Progenza (STEP) trial on patients with knee osteoarthritis (OA) delivered positive results which were published in the Journal of Translational Medicine(see Note 1 below) in March 2018. The trial found a single injection(see Note 2 below) of Progenza into the knee to be safe and well tolerated by patients, delivering durable and clinically meaningful pain relief for patients with knee OA. Progenza was shown to deliver a statistically significant improvement to lateral tibial cartilage volume in patients injected with 3.9 million cells of Progenza, compared to worsening placebo patients (p=0.028). The assessment was made from examination of the knee joint structure by MRI.

    Additional Progenza Highlights Include:

    - The United States Patent Office issuing a notice of allowance for a US patent for Progenza(see Note 3 below) in July 2018, covering the composition, manufacture and use of Progenza in the treatment of a wide range of inflammatory conditions, including osteoarthritis.

    - The granting of an Advanced Therapy Medicinal Therapy (ATMT) classification by the Committee for Advanced Therapies of the European Medicines Agency, recognising Progenza as a regenerative therapy within European Union's legal and regulatory framework(see Note 4 below).

    Sygenus Delivers Positive Results in Preclinical Pain Study

    In September 2017, Regeneus released positive results of a preclinical study and the effects of Sygenus on post-operative pain. MSCs have been previously shown to improve pain through known anti-inflammatory benefits. Sygenus was shown to deliver a sustained analgesic effect, which was longer-lasting than morphine, in the first ever known demonstration of this effect from mesenchymal stem cells (MSCs) and their secretions. The Company continues to conduct preclinical studies of Sygenus and Progenza in the treatment of pain as it looks to determine optimised doses and routes of administration. A preclinical study in neuropathic pain is also underway.

    Additional Sygenus Highlights Include:

    - Positive results from the topical application of Sygenus gel in treating acne in adults. The gel was well tolerated and found to significantly reduce the appearance of lesions and significantly reduced patients' acne global severity score after the 6-week period.

    - Positive results from the topical application of Sygenus gel to significantly lighten the colour of age spots. 95% of age spots were smaller and 63% of age spots were both smaller and lighter at eight weeks. The gel was well tolerated by patients.

    - The granting of a broad Australian Patent for the topical application of Sygenus for the treatment of aging skin and age spots.

    - The granting of a Chinese patent for the use of Sygenus in the topical treatment of acne, providing commercial rights in China to the year 2023.

    Cancer Vaccine Phase 1 ACTIVATE Trial Meets Primary Endpoints of Safety and Tolerability

    During the period, the Company completed recruitment for the Phase 1 Safety Study (ACTIVATE trial) of the Company's cancer vaccine immunotherapy technology RGSH4K across a wide range of tumours in humans.

    The trial is a single centre, open label, Phase 1 dose escalating study to evaluate the safety, tolerability and preliminary efficacy of RGSH4K and determine the active dose(s) to take into future trials.

    During the study, a total of 3 vaccines of RGSH4K were given at 3-week intervals to 12 heavily pre-treated patients with multiple types of advanced tumours. All dose levels were safe and well-tolerated, meeting the study's safety primary endpoint, with no dose limiting toxicities and no serious adverse events related to the vaccine.

    On 30 July 2018, the Company announced the ACTIVATE trial had met its primary endpoint of safety and tolerability and showed encouraging signs of immune stimulation in patients from each cohort, as demonstrated by changes in cancer markets, immune cells and cytokines, in one or more patients at all three dose levels. Some patients showed preliminary indications of anti-tumour activity, however long-term follow up of 50% of the patients continues.

    Other Achievements:

    - Recruitment is currently underway for pre-pivotal trial assessing Cryoshot for the treatment of canine osteoarthritis

    - Recruitment continuing for Kvax canine cancer vaccine - a similar technology to RGSH4K - with early indications showing no safety concerns

    Financial Overview

    Financial metrics for the year ended 30 June 2018 include:

    - Operating loss of $5.18m (FY17: $3.27m profit, driven by $8.9m AGC licence fee revenue), with next AGC licence milestone fee revenue due in Q2 FY19

    - R&D tax incentive of $2.16m (FY17: $2.61m)

    - Quarterly cash used in operations (excluding R&D tax incentive and FY17 AGC licence revenue) of $1.7m, in line with FY17

    - Loan facility secured of $1.9m repayable on the earlier of receipt of next AGC milestone payment; receipt of FY19 R&D Tax incentive rebate for FY19 and 30 September 2019


    The Company remains poised to deliver on a number of important commercial, clinical and R&D milestones FY19 and into FY20, including:

    - Securing its first clinical licence for Progenza in Japan

    - Progressing the clinical development of Progenza for osteoarthritis in Japan

    - Commencing manufacturing of cGMP Progenza in Japan under the Company's existing strategic collaboration and licensing agreement with AGC

    - Securing additional licensing opportunities for Progenza in additional key territories, including the USA, China and the European Union

    - Progressing the development of Progenza for specific pain indications

    - Progressing the development of Sygenus for specific pain and dermatological indications

    - Advancing licensing discussions for RGSH4K following positive ACTIVATE trial results

    - Reporting on CryoShot canine pre-pivotal trial and advancing licensing discussions.


    1 Kuah et al. JTranslMed (2018) 16:49. This article is available via Regeneus' company website.

    2 Results for injections of 3.9 million cells and 6.7 million cells.

    3 US Patent Application Number 14/342479 "Therapeutics using adipose cells and cell secretions".

    4 Article 2 (4) of Regulation (EC) No 1394/2007.

    Sandra McIntosh
    Company Secretary and Investor Relations
    T: +61-2-9499-8010
    Imogen Conyers
    Media and Capital Partners
    T: +61-405-191-257

    0 0

    Your directors present their report, together with the financial statements, on the consolidated entity (referred to hereafter as the 'Group') consisting of The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF) (referred to hereafter as the 'Company') and the entities it controlled at the end of, or during, the half-year ended 30 June 2018.

    Review of Operations

    Establishment of Executive and Management Leadership Teams

    THC announced the appointment of Ken Charteris as the Group Chief Executive Officer on 11 July 2018 in addition to a number of other key strategic appointments over the past half year across both its global medicinal cannabis operations and its North American hydroponics business.

    Group CEO, Ken Charteris, an experienced bio-tech and pharmaceuticals executive is supported by a global team who each have significant experience working with working in the pharmaceuticals and hydroponics industries.

    The Medicinal Cannabis leadership team is headed up by Dr Andrew Beehag and includes Katy Williams-Day as Product & Regulatory Affairs Manager, John Hall as an expert in Cannabis Strain Development and R&D, and Dr Michael Harrison as manager of the Southport bio-pharmaceutical facility.

    The Company also secured the continued services of Mr Jason Colquhoun, who is the head of the Company's revenue generating global hydroponics division. Jason is overseeing the expansion of the Company's hydroponics operations as it seeks to take advantage of the burgeoning micro-LP and home-grower markets in Canada following recent legislative changes and expands into the greater North American and European markets.

    Manufacture, Product Development and Distribution of Hydroponic Equipment

    The Company remains committed to the continued expansion of the Company's global revenue-generating hydroponics operation, Crystal Mountain Products. The Company has recently entered into an agreement with BioFloral, an east coast Canadian hydroponics business who will together work toward building a distribution network for the Company's products across North America.

    Increased Medicinal Cannabis Growing and R&D Capabilities

    The Company also expanded its growing capability significantly in the period, having secured an additional growing site in Northern NSW which it expects to develop to be able to cultivate up to 600,000 plants per year.

    The large-scale capacity will allow the Company to grow plants using both its proprietary strain IP and imported strains from commercial partners attracted in the first half of 2018.

    The Company continues to be engaged with the relevant Australian Government authorities to pursue the Company's licencing and permitting program for its medicinal cannabis operations.

    Pharma-grade Bio-manufacturing facility enabling full sale pharma production

    The Company acquired a bio-pharmaceutical manufacturing facility on 1 May 2018 for $2.55 million. Following a revaluation of the facility by AON Valuation Services, the asset now sits on the Company's balance sheet at over $16 million. The acquisition secures an industry-leading asset for the Company allowing it to move towards the sale and export of locally produced medicinal cannabis products. The acquisition places the Company far ahead of other medicinal cannabis companies who lack any significant means of moving to full-scale commercial pharma-grade production of medicinal cannabis products in the near term.

    To view the full report, please visit:

    Henry Kinstlinger
    Joint Company Secretary
    The Hydroponics Company Limited
    P: +61-2-9251-7177
    Michael Lovesey
    Director Corporate Media Relations
    MMR Corporate Services Pty Ltd
    P: +61-2-9251-7177
    M: +61-449-607-636

    0 0

    Retech Technology Co. (ASX:RTE) ('Retech' or 'the Company') a leading Shanghai based E-Learning online platform and courseware technology solutions company, is pleased to provide the following financial update to accompany it's Half Year FY2018 report.


    - Strong growth delivered across all divisions, expected to continue into 2H2018

    - Net profit after tax increases by 50%, to RMB17.04 million (A$3.4 million - see Note below) as compared to RMB11.34 million (A$2.27 million) in the previous corresponding six- month period

    - Net revenue of RMB48.65 million (A$9.7 million) delivered, up 21% compared to RMB40.1 million (A$8 million) for the same period in FY17

    - RTE continues to target new clients across Asian markets and has a strong sales pipeline for the remainder of 2018

    Financial Update

    For the six-month period ended 30 June 2018, Retech delivered net profit after tax of RMB17.04 million (A$3.4 million), up 50% from RMB11.34 (A$2.27 million). Net profit before tax was RMB20.36 million (A$4.1 million), an increase of 29%, compared to the previous corresponding six-month period.

    Net profit after tax was driven by increased revenue, up 21%, to RMB48.65 million (A$9.7 million) from RMB40.1 million (A$8 million). Retech's Chinese subsidiaries benefited from a preferential tax rate as a result of their 'New Technology Enterprise' status.

    Retech's increase in revenue resulted from strong demand for enterprise online training solutions across mainland China, most notably within the finance, auto and high-tech industries.

    Operational Update

    Strong growth was delivered across all divisions especially within E-learning solutions, as a result of client acquisitions and streamlined operations.

    The Company continues to target and engage with new customers across all industries as it builds its sales pipeline to support its expansion across the Asian and Australian markets. As an example Retech signed a software supply agreement with Bank of China in Q2 2018, for the provision of a bespoke online training platform to support the development of its employees in China.

    Further to this, the Company is actively developing its online learning operations within Australia

    Liu Cheng, Chief Executive Officer Commented:

    "I am pleased to be able to report a strong financial result for the Half Year. We continue to focus on expanding our customer base through the optimisation of cutting edge business processes".

    Note: A$ 1 - RMB 4.99 (29 August 2018)

    To view the Half Year Report, please visit:

    Corporate Enquiries
    Elly Yu
    Retech Technology Co., Ltd
    T: +86-2-5566-6166
    Media Enquiries
    Alex Liddington-Cox
    Media & Capital Partners
    T: +61-474-701-469

    0 0

    MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's latest Investor Presentation.


    Global cannabis investment company

    - Listed on the ASX and trades with the code "MMJ"

    o Circa 16,000 shareholders; none are substantial (i.e. no single holding of 5% or more)

    o 27.5 cents per share NTA at 30 June 2018

    - Sydney HQ

    o Global network of cannabis industry contacts and deal flow

    - Portfolio of minority interests

    o Investing up to $5 million per opportunity

    o Targeting investments in private companies, early stage through to pre-lPO

    - Performance measured by MOIC

    Note: "MOIC" is multiple on invested capital (pre-tax and transaction costs). "NTA" means net tangible assets.

    To view the full presentation, please visit:

    Investor and Media Enquiries:
    Jason Conroy
    Chief Executive Officer
    T: +61-2-8098-0819

    0 0

    Kingston Resources Limited (ASX:KSN) (Kingston or the Company) is pleased to announce it has successfully completed the sale of its Northern Territory lithium assets, (see ASX Announcement 5 July 2018). The $1,800,000 sale consideration has now been received by Kingston.

    Kingston Resources Limited
    T: +61-2-8021-7492

older | 1 | .... | 279 | 280 | (Page 281) | 282 | 283 | .... | 321 | newer